Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy

被引:7
作者
Song, Jianxun [1 ]
机构
[1] Penn State Univ, Dept Microbiol & Immunol, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA
关键词
Stem cells; Regulatory T cells; Immunotherapy; Tolerance; T cells; Diabetes; PLURIPOTENT STEM-CELLS; VERSUS-HOST-DISEASE; SELF-ANTIGEN; AUTOIMMUNITY; THERAPY; NOTCH; MICE; LYMPHOCYTES; EXPRESSION; GENERATION;
D O I
10.4110/in.2016.16.5.281
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4+ regulatory T cells (Tregs) are essential for normal immune surveillance, and their dysfunction can lead to the development of autoimmune diseases, such as type-1 diabetes (T1D). T1D is a T cell-mediated autoimmune disease characterized by islet beta cell destruction, hypoinsulinemia, and severely altered glucose homeostasis. Tregs play a critical role in the development of T1D and participate in peripheral tolerance. Pluripotent stem cells (PSCs) can be utilized to obtain a renewable source of healthy Tregs to treat T1D as they have the ability to produce almost all cell types in the body, including Tregs. However, the right conditions for the development of antigen (Ag)-specific Tregs from PSCs (i.e., PSC-Tregs) remain undefined, especially molecular mechanisms that direct differentiation of such Tregs. Auto Ag-specific PSC-Tregs can be programmed to be tissue-associated and infiltrate to local inflamed tissue (e.g., islets) to suppress autoimmune responses after adoptive transfer, thereby avoiding potential overall immunosuppression from non-specific Tregs. Developing auto Ag-specific PSC-Tregs can reduce overall immunosuppression after adoptive transfer by accumulating inflamed islets, which drives forward the use of therapeutic PSC-Tregs for cell-based therapies in T1D.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 36 条
  • [1] Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells
    Aschenbrenner, Katharina
    D'Cruz, Louise M.
    Vollmann, Elisabeth H.
    Hinterberger, Maria
    Emmerich, Jan
    Swee, Lee Kim
    Rolink, Antonius
    Klein, Ludger
    [J]. NATURE IMMUNOLOGY, 2007, 8 (04) : 351 - 358
  • [2] Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi
    Bacher, P.
    Kniemeyer, O.
    Schoenbrunn, A.
    Sawitzki, B.
    Assenmacher, M.
    Rietschel, E.
    Steinbach, A.
    Cornely, O. A.
    Brakhage, A. A.
    Thiel, A.
    Scheffold, A.
    [J]. MUCOSAL IMMUNOLOGY, 2014, 7 (04) : 916 - 928
  • [3] Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
    Bendle, Gavin M.
    Linnemann, Carsten
    Hooijkaas, Anna I.
    Bies, Laura
    de Witte, Moniek A.
    Jorritsma, Annelies
    Kaiser, Andrew D. M.
    Pouw, Nadine
    Debets, Reno
    Kieback, Elisa
    Uckert, Wolfgang
    Song, Ji-Ying
    Haanen, John B. A. G.
    Schumacher, Ton N. M.
    [J]. NATURE MEDICINE, 2010, 16 (05) : 565 - U98
  • [4] Type 1 diabetes immunotherapy using polyclonal regulatory T cells
    Bluestone, Jeffrey A.
    Buckner, Jane H.
    Fitch, Mark
    Gitelman, Stephen E.
    Gupta, Shipra
    Hellerstein, Marc K.
    Herold, Kevan C.
    Lares, Angela
    Lee, Michael R.
    Li, Kelvin
    Liu, Weihong
    Long, S. Alice
    Masiello, Lisa M.
    Vinh Nguyen
    Putnam, Amy L.
    Rieck, Mary
    Sayre, Peter H.
    Tang, Qizhi
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (315)
  • [5] eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis
    Cheng, Y.
    Ren, X.
    Yuan, Y.
    Shan, Y.
    Li, L.
    Chen, X.
    Zhang, L.
    Takahashi, Y.
    Yang, J. W.
    Han, B.
    Liao, J.
    Li, Y.
    Harvey, H.
    Ryazanov, A.
    Robertson, G. P.
    Wan, G.
    Liu, D.
    Chen, A. F.
    Tao, Y.
    Yang, J-M
    [J]. ONCOGENE, 2016, 35 (49) : 6293 - 6308
  • [6] Cellular and Molecular Requirements for the Selection of In Vitro-Generated CD8 T Cells Reveal a Role for Notch
    Dervovic, Dzana D.
    Liang, Haydn C. -Y.
    Cannons, Jennifer L.
    Elford, Alisha R.
    Mohtashami, Mahmood
    Ohashi, Pamela S.
    Schwartzberg, Pamela L.
    Zuniga-Pfluecker, Juan Carlos
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 191 (04) : 1704 - 1715
  • [7] Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
    Di Stasi, Antonio
    Tey, Siok-Keen
    Dotti, Gianpietro
    Fujita, Yuriko
    Kennedy-Nasser, Alana
    Martinez, Caridad
    Straathof, Karin
    Liu, Enli
    Durett, April G.
    Grilley, Bambi
    Liu, Hao
    Cruz, Conrad R.
    Savoldo, Barbara
    Gee, Adrian P.
    Schindler, John
    Krance, Robert A.
    Heslop, Helen E.
    Spencer, David M.
    Rooney, Cliona M.
    Brenner, Malcolm K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) : 1673 - 1683
  • [8] Cutting Edge: Memory Regulatory T Cells Require IL-7 and Not IL-2 for Their Maintenance in Peripheral Tissues
    Gratz, Iris K.
    Truong, Hong-An
    Yang, Sara Hsin-Yi
    Maurano, Megan M.
    Lee, Karim
    Abbas, Abul K.
    Rosenblum, Michael D.
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 190 (09) : 4483 - 4487
  • [9] Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification
    Guo, Yalin
    Maillard, Ivan
    Chakraborti, Sankhamala
    Rothenberg, Ellen V.
    Speck, Nancy A.
    [J]. BLOOD, 2008, 112 (03) : 480 - 492
  • [10] Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity
    Haque, Mohammad
    Song, Jianyong
    Fino, Kristin
    Sandhu, Praneet
    Song, Xinmeng
    Lei, Fengyang
    Zheng, Songguo
    Ni, Bing
    Fang, Deyu
    Song, Jianxun
    [J]. SCIENTIFIC REPORTS, 2016, 6